Overall, Edwards enjoys a great deal of financial flexibility that would allow for more substantial acquisitions, if those opportunities were to arise. Edwards Lifesciences has come to dominate ...

Edwards Lifesciences Corporation (NYSE:EW) develops medical innovations for heart disease and critical care monitoring. Its ...

Edwards Lifesciences Corporation (NYSE:EW) shares are trading higher on Thursday. Stifel analyst Rick Wise upgraded Edwards from Hold to Buy, raising the price forecast to $90 from $75. Wise suggests ...

Although the revenue and EPS for Edwards Lifesciences (EW) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare ...

Despite guideline recommendations, the use of bioprosthetic heart valves has surpassed mechanical valves, but data from a large surgical database may lead to a reassessment of that practice.

Kennesaw State University mechanical engineering professor Philippe Sucosky has earned a prestigious American Heart Association (AHA) Institutional Enhancement Award to advance his study on bicuspid ...

Background Aortic stenosis is a degenerative condition with high mortality in its severe stages and no preventive treatment.

Patients aged between 50 to 70 years with a mechanical heart valve replacement had better long-term survival compared to ...

Titled "A Novel Microphysiological Valve-on-Chip for Elucidating the Mechano-Etiology of Bicuspid Aortic Valve Disease," Sucosky's project aims to build a device replicating the structure and ...

LOS ANGELES, CA—Among patients needing both aortic valve replacement and coronary revascularization, surgery is associated with lower morbidity and mortality compared with percutaneous methods, ...